↑N. Adham, H. T. Kao, L. E. Schecter, J. Bard, M. Olsen:Cloning of another human serotonin receptor (5-HT1F): a fifth 5-HT1 receptor subtype coupled to the inhibition of adenylate cyclase. In: Proceedings of the National Academy of Sciences. Band90, Nr.2, 15.Januar 1993, ISSN0027-8424, S.408–412, doi:10.1073/pnas.90.2.408, PMID 8380639.
↑T. W. Lovenberg, M. G. Erlander, B. M. Baron, M. Racke, A. L. Slone:Molecular cloning and functional expression of 5-HT1E-like rat and human 5-hydroxytryptamine receptor genes. In: Proceedings of the National Academy of Sciences of the United States of America. Band90, Nr.6, 15.März 1993, ISSN0027-8424, S.2184–2188, doi:10.1073/pnas.90.6.2184, PMID 8384716.
↑J. Erdmann, D. Shimron-Abarbanell, V. Shridhar, D. I. Smith, P. Propping:Assignment of the human serotonin 1F receptor gene (HTR1F) to the short arm of chromosome 3 (3p13-p14.1). In: Molecular Membrane Biology. Band14, Nr.3, Juli 1997, ISSN0968-7688, S.133–135, doi:10.3109/09687689709048173, PMID 9394293.
↑A. Maassen VanDenBrink, M. N. Vergouwe, R. A. Ophoff, S. L. Naylor, H. G. Dauwerse:Chromosomal localization of the 5-HT1F receptor gene: no evidence for involvement in response to sumatriptan in migraine patients. In: American Journal of Medical Genetics. Band77, Nr.5, 5.Juni 1998, ISSN0148-7299, S.415–420, PMID 9632173.
↑Michael T. Klein, Małgorzata Dukat, Richard A. Glennon, Milt Teitler:Toward selective drug development for the human 5-hydroxytryptamine 1E receptor: a comparison of 5-hydroxytryptamine 1E and 1F receptor structure-affinity relationships. In: The Journal of Pharmacology and Experimental Therapeutics. Band337, Nr.3, Juni 2011, ISSN1521-0103, S.860–867, doi:10.1124/jpet.111.179606, PMID 21422162, PMC3101003(freier Volltext).
↑David B. Wainscott, Joseph H. Krushinski, James E. Audia, John M. Schaus, John M. Zgombick:[3H]LY334370, a novel radioligand for the 5-HT1F receptor. I. In vitro characterization of binding properties. In: Naunyn-Schmiedeberg's Archives of Pharmacology. Band371, Nr.3, März 2005, ISSN0028-1298, S.169–177, doi:10.1007/s00210-005-1035-9, PMID 15900510.
↑Deyi Zhang, Dan Kohlman, Joseph Krushinski, Sidney Liang, Bai-Ping Ying:Design, synthesis and evaluation of bicyclic benzamides as novel 5-HT1F receptor agonists. In: Bioorganic & Medicinal Chemistry Letters. Band14, Nr.24, 20.Dezember 2004, ISSN0960-894X, S.6011–6016, doi:10.1016/j.bmcl.2004.09.079, PMID 15546719.